FEDERATED HERMES, INC. – Vertex Pharmaceuticals Incorporated Transaction History
FEDERATED HERMES, INC. portfolio value:
$45.28M
portfolio value
FEDERATED HERMES, INC. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -11.34% | -20.00K shares | -4.42M | $289.54 | 156.39K |
Q2 2022 | share | Decrease | -26.55% | -63.75K shares | -12.96M | $281.79 | 176.39K |
Q1 2022 | share | Decrease | -10.09% | -26.93K shares | 4.02M | $260.97 | 240.14K |
Q4 2021 | share | Increase | +6.56% | 16.44K shares | 13.18M | $222.45 | 267.08K |
Q3 2021 | share | Increase | +45.67% | 78.58K shares | 10.77M | $181.39 | 250.64K |
Q2 2021 | share | Decrease | -36.44% | -98.66K shares | -23.48M | $201.63 | 172.06K |
Q1 2021 | share | Decrease | -18.04% | -59.58K shares | -19.89M | $214.89 | 270.72K |
Q4 2020 | share | Decrease | -8.56% | -30.94K shares | -20.23M | $236.34 | 330.31K |
Q3 2020 | share | Decrease | -0.90% | -3.27K shares | -7.52M | $272.12 | 361.25K |
Q2 2020 | share | Decrease | -8.61% | -34.32K shares | 10.92M | $290.31 | 364.53K |
Q1 2020 | share | Decrease | -2.42% | -9.87K shares | 5.41M | $237.95 | 398.85K |
Q4 2019 | share | Increase | +7.20% | 27.45K shares | 24.89M | $218.95 | 408.73K |
Q3 2019 | share | Increase | +17.41% | 56.54K shares | 5.04M | $169.42 | 381.27K |
Q2 2019 | share | Decrease | -1.12% | -3.68K shares | -863K | $183.38 | 324.73K |
Q1 2019 | share | Increase | +29.45% | 74.72K shares | 18.37M | $183.95 | 328.41K |
Q4 2018 | share | Decrease | -15.90% | -47.94K shares | -16.09M | $165.71 | 253.69K |
Q3 2018 | share | Decrease | -23.80% | -94.21K shares | -9.14M | $192.74 | 301.63K |
Q2 2018 | share | Increase | +63.79% | 154.16K shares | 27.88M | $169.96 | 395.85K |
Q1 2018 | share | Increase | +390.63% | 192.42K shares | 32.00M | $162.98 | 241.68K |
Q4 2017 | share | Decrease | -3.95% | -2.02K shares | -416K | $149.86 | 49.26K |
Q3 2017 | share | Increase | +1.53% | 772 shares | 1.28M | $152.04 | 51.28K |
Q2 2017 | call | Decrease | -100.00% | -10K shares | -1.09M | $128.87 | 0 |
Q2 2017 | share | Decrease | -16.88% | -10.25K shares | -135K | $128.87 | 50.51K |
Q1 2017 | call | Increase | 0.00% | 10K shares | 1.09M | $109.35 | 10K |
Q1 2017 | share | Decrease | -43.91% | -47.57K shares | -1.33M | $109.35 | 60.77K |
Q4 2016 | share | Increase | +3.63% | 3.8K shares | -1.13M | $73.67 | 108.35K |
Q3 2016 | share | Decrease | -19.50% | -25.33K shares | -2.05M | $87.21 | 104.55K |
Q2 2016 | share | Decrease | -37.56% | -78.12K shares | -5.36M | $86.02 | 129.88K |
Q1 2016 | share | Decrease | -68.17% | -445.49K shares | -65.69M | $79.49 | 208.00K |